DK0877758T3 - Oprenset SR-p70-protein - Google Patents

Oprenset SR-p70-protein

Info

Publication number
DK0877758T3
DK0877758T3 DK97904481T DK97904481T DK0877758T3 DK 0877758 T3 DK0877758 T3 DK 0877758T3 DK 97904481 T DK97904481 T DK 97904481T DK 97904481 T DK97904481 T DK 97904481T DK 0877758 T3 DK0877758 T3 DK 0877758T3
Authority
DK
Denmark
Prior art keywords
protein
purified
sequences
tumor
gene
Prior art date
Application number
DK97904481T
Other languages
English (en)
Inventor
Daniel Caput
Pascual Ferrara
Ahmed Mourad Kaghad
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of DK0877758T3 publication Critical patent/DK0877758T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
DK97904481T 1996-02-02 1997-02-03 Oprenset SR-p70-protein DK0877758T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9601309A FR2744455B1 (fr) 1996-02-02 1996-02-02 Nouvelles sequences d'acides nucleiques de la famille des facteurs suppresseurs de tumeurs, produits d'expression correspondants et leurs applications
PCT/FR1997/000214 WO1997028186A1 (fr) 1996-02-02 1997-02-03 PROTEINE PURIFIEE SR-p70

Publications (1)

Publication Number Publication Date
DK0877758T3 true DK0877758T3 (da) 2009-07-06

Family

ID=9488795

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97904481T DK0877758T3 (da) 1996-02-02 1997-02-03 Oprenset SR-p70-protein

Country Status (16)

Country Link
US (3) US7557187B2 (da)
EP (1) EP0877758B1 (da)
JP (1) JP3447301B2 (da)
AT (1) ATE427959T1 (da)
AU (1) AU1727597A (da)
BR (1) BR9710919A (da)
DE (1) DE69739346D1 (da)
DK (1) DK0877758T3 (da)
ES (1) ES2322971T3 (da)
FR (1) FR2744455B1 (da)
MX (1) MX9806041A (da)
NO (1) NO323285B1 (da)
PT (1) PT877758E (da)
TW (1) TW515802B (da)
WO (1) WO1997028186A1 (da)
ZA (1) ZA97835B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6451979B1 (en) 1997-05-12 2002-09-17 Dana-Farber Cancer Institute, Inc. Methods of treatment using NBS-1, antibodies and proteins thereto, and uses of the antibodies
DE19736691A1 (de) * 1997-08-22 1999-02-25 Michael Prof Dr Med Giesing Verfahren zur Charakterisierung und Identifizierung disseminierter und metastasierter Krebszellen
US7294459B1 (en) 1997-10-15 2007-11-13 President And Fellows Of Harvard College Cell regulatory genes, encoded products, and uses related thereto
US7030227B1 (en) 1997-10-15 2006-04-18 President & Fellows Of Harvard College Cell regulatory genes, encoded products, and uses related thereto
WO1999019357A2 (en) * 1997-10-15 1999-04-22 President And Fellows Of Harvard College Cell regulatory genes, encoded products, and uses related thereto
ATE512162T1 (de) 1998-03-27 2011-06-15 Otsuka Pharma Co Ltd Antikörper gegen das p51 protein
AU3208699A (en) 1998-03-27 1999-10-18 Johns Hopkins University, The P40 protein acts as an oncogene
CA2364609A1 (en) * 1999-03-16 2000-09-21 Exelixis, Inc. Insect p53 tumor suppressor genes and proteins
AU1346501A (en) * 1999-10-29 2001-05-14 Chiron Corporation Methods for improving viral vector titers and reducing cell death in cell cultures
CN1296966A (zh) 1999-11-23 2001-05-30 上海博容基因开发有限公司 一种新的多肽——人sr剪接因子52和编码这种多肽的多核苷酸
US20060088825A1 (en) * 2001-09-17 2006-04-27 Ian Hayes Human delta-n p73 molecules and uses thereof
ITMI20042227A1 (it) * 2004-11-19 2005-02-19 Ist Fisioterap Ospitalroma Peptide in grado di rompere il complesso m-p53-p63, m-p53-p73 e m-p53-relative proteine isoformi formatosi nelle cellule tumorali e relativi impieghi in campo farmacologico

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE118042T1 (de) * 1988-12-22 1995-02-15 Lilly Co Eli Rekombinante dna enthaltende expressionsvektoren und für isopenicillin-n-epimerase-(racemase)- aktivität kodierende dns-verbindungen.
FR2692594A1 (fr) * 1992-06-22 1993-12-24 Perez Jean Claude Le Langage Global de l'Expression des gènes: Applications à l'analyse, au contrôle et à l'optimisation des interactions globales entre Régions non codantes et codantes de divers gènes.
FR2693594B1 (fr) * 1992-07-07 1994-08-26 Thomson Csf Détecteur d'ondes électromagnétiques à puits quantiques.
RU95105971A (ru) * 1992-07-10 1997-03-20 Энерджи Биосистемз Корпорейшн (US) Днк, векторы, микроорганизм, бактерия, способы десульфуризации ископаемого топлива, зонд, белки
US6051384A (en) * 1992-09-30 2000-04-18 Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts Method of detecting p53-specific antibodies
US5532348A (en) 1993-07-30 1996-07-02 United States Of America E6 associated protein and methods of use thereof
US5912143A (en) * 1996-12-27 1999-06-15 Incyte Pharmaceuticals, Inc. Polynucleotides encoding a human mage protein homolog
US6451979B1 (en) 1997-05-12 2002-09-17 Dana-Farber Cancer Institute, Inc. Methods of treatment using NBS-1, antibodies and proteins thereto, and uses of the antibodies
WO1999066946A1 (en) 1998-06-24 1999-12-29 Trustees Of The University Of Pennsylvania Compositions and methods for inducing apoptosis in e6-expressing cells

Also Published As

Publication number Publication date
NO323285B1 (no) 2007-02-26
ES2322971T3 (es) 2009-07-02
EP0877758A2 (fr) 1998-11-18
US7838648B2 (en) 2010-11-23
FR2744455A1 (fr) 1997-08-08
JP3447301B2 (ja) 2003-09-16
TW515802B (en) 2003-01-01
US20110020951A1 (en) 2011-01-27
EP0877758B1 (fr) 2009-04-08
ATE427959T1 (de) 2009-04-15
US20090258409A1 (en) 2009-10-15
NO983537D0 (no) 1998-07-31
BR9710919A (pt) 1999-08-17
WO1997028186A1 (fr) 1997-08-07
PT877758E (pt) 2009-07-10
MX9806041A (es) 1998-11-30
ZA97835B (en) 1998-09-10
US7557187B2 (en) 2009-07-07
NO983537L (no) 1998-10-02
US20050202016A1 (en) 2005-09-15
FR2744455B1 (fr) 1998-04-24
AU1727597A (en) 1997-08-22
JP2000511765A (ja) 2000-09-12
DE69739346D1 (de) 2009-05-20

Similar Documents

Publication Publication Date Title
ATE309536T1 (de) Methoden zur verwendung von randomisierten zinkfingerprotein-bibliotheken zur identifizierung von genfunktionen
FI962247A (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät
DE69636866D1 (en) Reverse "two-hybrid"-systeme
RU95110871A (ru) Способы определения нуклеотидной последовательности
DE69604298T2 (de) Varianten des grünen fluoreszenzproteins, gfp
EP0804609A4 (en) NEW GENES OF RESPONSE p53
EP1135532A4 (en) FLUORESCENT PROTEINS BELONGING TO NON-BIOLUMINESCENT SPECIES OF THE ANTHOZOA CLASS, GENES ENCODING THE SAME AND USES THEREOF
DE69932599D1 (de) Künstliche chromosomen, die die genetische information für die bildung von rekombinantem virus enthalten
ATE427959T1 (de) Gereinigtes sr-p70 protein
WO2002040668A3 (de) Proteine und den proteinen zugrundeliegende dna-sequenzen mit funktion bei entzündungsereignissen
DK1082423T3 (da) Cyclin E2-gener og -proteiner
FI961202A0 (fi) Grb3-3-geeni, sen variantteja ja niiden käyttöjä
ATE305037T1 (de) Peptide, die fähig sind die sh3-domäne des gap- proteins zu binden, ihre kodierende dns, ihre zubereitung und verwendung
DE69728897D1 (de) Saeugetierchemokine
DE59712554D1 (de) Rekombinante expression von s-layer-proteinen
DK1005532T3 (da) Isolerede nukleinsyremolekyler kodende for SSX familiemedlemmer og anvendelser deraf
HUP0001857A2 (hu) Bakteriális plazmidok
AU2256197A (en) High affinity nucleic acid ligands of complement system proteins
NZ512332A (en) Potassium channel interactors and uses therefor
WO2000046391A3 (en) Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
ATE319826T1 (de) Minimale promotoren und ihre verwendung
HUP9901346A2 (hu) Deltap62 polipeptid és variánsai, ezeket kódoló nukleinsav-szekvenciák és felhasználásuk
WO2002092840A3 (en) Agents that regulate apoptosis
AU1323200A (en) Isolated nucleic acid molecules which encode scp proteins, and uses thereof
ZA974962B (en) Isolated nucleic acid molecules which are members of the MAGE-B family and uses thereof.